Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in ...

Following her breast cancer diagnosis, Guerdy Abraira utilized genomic testing to gain clarity on her treatment path. For ...

Indiana University cancer specialists just helped put Indianapolis on the global oncology map, serving as authors and ...

Radical cystectomy, or complete bladder removal, remains the standard and most effective surgery for muscle‑invasive bladder cancer because it offers the strongest chance of cure when the disease has ...

Kidney cancer care has seen advances over the past few decades, reflecting both improved diagnostic capabilities and less invasive treatment approaches. Kidney cancer management has seen notable ...

Screening women with dense breasts with both molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) increased overall invasive cancer detection while modestly increasing the recall rate ...

Jessica Domann has brought in more preventative care and created an external comprehensive cancer benefits guide for ...

According to BCC Research, growing emphasis on early detection, liquid biopsy technologies, and patient-friendly diagnostic ...

The new test removes the need for patients to have to undergo physical examinations, scans and biopsies to see if cancer has ...